Natco Pharma expected to touch 170-172: Kotak Securities

Shrikant Chouhan, senior vice president, Technical Research, Kotak Securities, in a chat with ET Now talks about Natco Pharma.

Shrikant Chouhan, senior vice president, Technical Research, Kotak Securities, in a chat with ET Now talks about Natco Pharma.

Do you like Natco Pharma? Do you look at the charts at all?

Yes, the stock is good and even the chart is also very strong on daily as well as on weekly basis. The stock is having very good support at very nearby 143-145 levels and we can expect again 170-172 in the near term because the stock is even more bullish on the long-term patterns.
ADVERTISEMENT
READ MORE

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Natco Pharma expected to touch 170-172: Kotak Securities
Text Size:AAA
Success
This article has been saved

*

+